The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Non-endoscopic Brushing of the Esophagus Using a Non-endoscopic Inflatable Balloon of the Esophagus in Screening for Barrett Esophagus

Not Applicable

Completed

Conditions: Barrett Esophagus

Interventions: Device: non-endoscopic inflatable balloon for the esophagus
Other: Questionnaire Administration
Other: Laboratory Biomarker Analysis
Procedure: esophagogastroduodenoscopy

First Posted Date: 2015-05-21

Last Posted Date: 2019-11-06

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 156

Registration Number: NCT02451124

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program

Not Applicable

Terminated

Conditions: Prostate Carcinoma

Interventions: Other: Educational Intervention
Procedure: digital rectal examination
Other: Pre-test administration
Other: Survey Administration
Other: Post test administration
Other: Prostate-specific antigen measurement

First Posted Date: 2015-04-17

Last Posted Date: 2022-07-25

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 319

Registration Number: NCT02419846

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

Not Applicable

Completed

Conditions: Stage I Breast Cancer
Stage II Breast Cancer

Interventions: Drug: Indocyanine Green Solution
Radiation: Technetium Tc-99m Sulfur Colloid
Procedure: Lymphoscintigraphy
Procedure: Axillary Lymph Node Biopsy

First Posted Date: 2015-04-17

Last Posted Date: 2022-06-30

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 102

Registration Number: NCT02419807

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Instititute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans

Not Applicable

Completed

Conditions: Skin Carcinoma
Skin Melanoma

Interventions: Other: Written Educational Brochure
Other: Online educational video

First Posted Date: 2015-04-16

Last Posted Date: 2015-12-03

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 143

Registration Number: NCT02417948

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Phase 2

Terminated

Conditions: Stage IB Esophageal Adenocarcinoma
Stage IIA Esophageal Adenocarcinoma
Stage IIB Esophageal Adenocarcinoma
Stage IIIA Esophageal Adenocarcinoma
Stage IIIB Esophageal Adenocarcinoma
Stage IIIC Esophageal Adenocarcinoma

Interventions: Drug: Paclitaxel
Drug: Oxaliplatin
Drug: Leucovorin Calcium
Drug: Carboplatin
Radiation: Radiation Therapy
Drug: Fluorouracil
Procedure: Therapeutic Conventional Surgery
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-03-19

Last Posted Date: 2018-02-13

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 1

Registration Number: NCT02392377

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

Not Applicable

Terminated

Conditions: Recurrent Hypopharyngeal Squamous Cell Carcinoma
Recurrent Oropharyngeal Squamous Cell Carcinoma
Stage III Hypopharyngeal Squamous Cell Carcinoma
Stage III Laryngeal Squamous Cell Carcinoma
Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma
Stage IVA Hypopharyngeal Squamous Cell Carcinoma
Stage IVB Laryngeal Squamous Cell Carcinoma
Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma
Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma
Stage III Oral Cavity Squamous Cell Carcinoma

Interventions: Radiation: Stereotactic Body Radiation Therapy
Device: Positron Emission Tomography
Device: Computed Tomography
Other: Quality-of-Life Assessment

First Posted Date: 2015-03-17

Last Posted Date: 2019-01-24

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 3

Registration Number: NCT02388932

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States